These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24178909)

  • 1. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
    Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
    Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
    Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
    Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
    Galoian K; Abrahamyan S; Chailyan G; Qureshi A; Patel P; Metser G; Moran A; Sahakyan I; Tumasyan N; Lee A; Davtyan T; Chailyan S; Galoyan A
    Int J Oncol; 2018 Jan; 52(1):139-154. PubMed ID: 29138803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
    Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
    Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
    Galoian K; Temple TH; Galoyan A
    Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
    Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
    Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells.
    Lin CY; Wang SW; Chen YL; Chou WY; Lin TY; Chen WC; Yang CY; Liu SC; Hsieh CC; Fong YC; Wang PC; Tang CH
    Cell Death Dis; 2017 Aug; 8(8):e2964. PubMed ID: 28771226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops.
    Galoian K; Temple HT; Galoyan A
    Tumour Biol; 2012 Jun; 33(3):885-90. PubMed ID: 22246604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.
    Galoian K; Scully S; Galoyan A
    Neurochem Res; 2009 Feb; 34(2):379-85. PubMed ID: 18612811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
    Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
    Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
    Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
    Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A.
    Lu Y; Li F; Xu T; Sun J
    Oncol Res; 2016; 23(4):155-63. PubMed ID: 27053344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
    Huang K; Chen J; Yang MS; Tang YJ; Pan F
    Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of microRNAs expressions in chondrosarcoma.
    Yoshitaka T; Kawai A; Miyaki S; Numoto K; Kikuta K; Ozaki T; Lotz M; Asahara H
    J Orthop Res; 2013 Dec; 31(12):1992-8. PubMed ID: 23940002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
    Zhu Z; Wang CP; Zhang YF; Nie L
    Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
    Cao J; Huang W
    PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.
    Galoian K; Scully S; McNamara G; Flynn P; Galoyan A
    Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.
    Mutlu S; Mutlu H; Kirkbes S; Eroglu S; Kabukcuoglu YS; Kabukcuoglu F; Duymus TM; ISık M; Ulasli M
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2384-8. PubMed ID: 26214773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.